Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Scheidemann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Archives of Dermatological Research|July 30, 2008
Selectable bicistronic vectors in skin gene therapyFrank Scheidemann, Jean-Philippe Therrien, Wolfgang Pfützner
Experimental Dermatology|November 6, 2009
In vivo synthesis and secretion of erythropoietin by genetically modified primary human keratinocytes grafted onto immunocompromised miceFrank Scheidemann, Jean-Philippe Therrien, Jon Vogel, et al.
Experimental Dermatology|March 12, 2008
The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblastsFrank Scheidemann, Maria Löser, Andrea Niedermeier, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Archives of Dermatological Research|July 30, 2008
Selectable bicistronic vectors in skin gene therapyFrank Scheidemann, Jean-Philippe Therrien, Wolfgang Pfützner
Experimental Dermatology|November 6, 2009
In vivo synthesis and secretion of erythropoietin by genetically modified primary human keratinocytes grafted onto immunocompromised miceFrank Scheidemann, Jean-Philippe Therrien, Jon Vogel, et al.
Experimental Dermatology|March 12, 2008
The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblastsFrank Scheidemann, Maria Löser, Andrea Niedermeier, et al.
Pageof 1